Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study to Collect Safety and Effectiveness Information on Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy Who Have Completed Prior Studies With Vamorolone

NCT06713135 is registered in ClinicalTrials.gov with Santhera Pharmaceuticals as lead sponsor.

NCT NCT06713135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06713135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study to Collect Safety and Effectiveness Information on Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy Who Have Completed Prior Studies With Vamorolone
Lead sponsor
Santhera Pharmaceuticals
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 10, 2024
Completion date
September 30, 2028
Enrollment
80 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy